Mitesco (MITI) Liabilities from Discontinued Operations (2014 - 2023)

Mitesco (MITI) reported Liabilities from Discontinued Operations of 9955164.0 for Q3 2023, up 363.96% quarter-over-quarter from 2145706.0 in Q4 2022.

Mitesco (MITI) Liabilities from Discontinued Operations (2014 - 2023) Analysis & Trends

Mitesco (MITI) has 3 years of Liabilities from Discontinued Operations data on file, last reported at 9955164.0 in Q3 2023.

  • Liabilities from Discontinued Operations for Q3 2023 came in at 9955164.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2023 was 9955164.0 (changed N/A YoY), and the FY2022 annual result was 2145706.0, changed N/A from the prior year.
  • Liabilities from Discontinued Operations improved to 9955164.0 in Q3 2023 per MITI's latest filing, from 2145706.0 in the prior quarter.
  • Over five years, Liabilities from Discontinued Operations peaked at 9955164.0 in Q3 2023 and troughed at 2145706.0 in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 24.83 Bn 17.52 Bn 662.02 Mn
2 BrightSpring Health Services 13.57 Bn 12.69 Bn 482.22 Mn
3 Healthequity 7.20 Bn 6.93 Bn 256.31 Mn
4 Hinge Health 5.42 Bn 5.11 Bn 154.23 Mn
5 10x Genomics 4.46 Bn 3.92 Bn 106.18 Mn
6 Doximity 3.81 Bn 3.06 Bn 125.97 Mn
7 Waystar Holding 3.52 Bn 3.36 Bn 268.04 Mn
8 Privia Health 2.94 Bn 2.57 Bn 595.71 Mn
9 Omnicell 1.76 Bn 1.59 Bn 140.36 Mn
10 Mitesco - - -

Historic Data

Download Data
DateValue
Sep 30, 2023 9.96 Mn
Sep 30, 2023 9.96 Mn
Dec 31, 2022 2.15 Mn
Dec 31, 2022 2.15 Mn
Dec 31, 2014 3.10 Mn
Dec 31, 2014 3.10 Mn